Based on the characteristics of neuroendocrine tumors using MTC, detecting serum biomarker Ctn levels (individually or in combination with CEA testing) has been used for preoperative diagnosis (24). The gene discussed is CEACAM5; the disease is medullary thyroid gland carcinoma.